Growth Metrics

Eli Lilly (LLY) Operating Income Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 45.29%
Dec 31, 2025 29.26%
Sep 30, 2025 44.38%
Jun 30, 2025 37.31%
Mar 31, 2025 26.24%
Dec 31, 2024 28.03%
Sep 30, 2024 23.61%
Jun 30, 2024 20.49%
Mar 31, 2024 16.78%
Dec 31, 2023 16.17%
Sep 30, 2023 19.33%
Jun 30, 2023 6.88%
Mar 31, 2023 3.40%
Dec 31, 2022 11.12%
Sep 30, 2022 8.56%
Jun 30, 2022 5.71%
Mar 31, 2022 19.50%
Dec 31, 2021 17.45%
Sep 30, 2021 15.79%
Jun 30, 2021 8.07%
Mar 31, 2021 11.61%
Dec 31, 2020 27.11%
Sep 30, 2020 4.96%
Jun 30, 2020 8.53%
Mar 31, 2020 13.07%
Dec 31, 2019 11.95%
Sep 30, 2019 16.82%
Jun 30, 2019 11.43%
Mar 31, 2019 6.84%
Dec 31, 2018 7.44%
Sep 30, 2018 -1.73%
Jun 30, 2018 0.35%
Mar 31, 2018 -1.29%
Dec 31, 2017 -0.69%
Sep 30, 2017 0.24%
Jun 30, 2017 0.78%
Mar 31, 2017 -5.58%
Dec 31, 2016 -0.28%
Sep 30, 2016 -9.01%
Jun 30, 2016 -9.19%
Mar 31, 2016 -12.72%
Dec 31, 2015 -12.49%
Sep 30, 2015 -8.03%
Jun 30, 2015 -9.75%
Mar 31, 2015 -11.98%
Dec 31, 2014 -7.38%
Sep 30, 2014 -6.30%
Jun 30, 2014 -9.88%
Mar 31, 2014 -13.16%